Search
forResearch 10 of 137
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Baricitinib for the Treatment of Alopecia Areata
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Alopecia Areata and Season of Onset: A Retrospective Study of 492 Cases
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Journal of Population Therapeutics and Clinical Pharmacology
- Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →